FOR-ROBIN, INC.

Williamsville, NY · Biotech · Private

Humanized antibody (hJAA-4) conjugated to PET imaging agents for lung cancer detection

for-robin.com →
Grants
$2.6M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy$973,366
Federal grantDepartment of Health and Human Services · Phase II · Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy$1,013,625
Federal grantDepartment of Health and Human Services · Phase I · JAA-F11 Anti-Thomsen-Friedenreich Antigen Targeted Imaging for Lung Cancer Differential Diagnosis$304,318
Federal grantDepartment of Health and Human Services · Phase I · JAA-F11 Anti-Thomsen-Friedenreich Antigen Targeted Imaging for Lung Cancer Differential Diagnosis$304,318
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1653ALPH TECHNOLOGIES LLC——
1654Doric Pharma——
1655AGENOVIR CORPORATION——
1656FOR-ROBIN, INC.——
1657OncoSpherix, Inc.——
1658PHAGE REFINERY, INC.——
1659JUVENA THERAPEUTICS INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.